Not available
Quote | Compugen Ltd. (NASDAQ:CGEN)
Last: | $1.89 |
---|---|
Change Percent: | -0.53% |
Open: | $1.91 |
Close: | $1.89 |
High: | $1.96 |
Low: | $1.87 |
Volume: | 202,009 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
News | Compugen Ltd. (NASDAQ:CGEN)
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 PR Newswire HOLON, Israel , April 10, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pione...
Compugen to Participate in Two Upcoming Investor Conferences PR Newswire HOLON, Israel , April 3, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, tod...
Message Board Posts | Compugen Ltd. (NASDAQ:CGEN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CGEN News Article - Compugen Doses First Patient in Triple Combination COM701, COM902 | whytestocks | investorshangout | 03/06/2023 3:55:49 PM |
whytestocks: $CGEN News Article - Why Compugen Shares Are Up Today | whytestocks | investorshangout | 02/28/2023 5:30:50 PM |
whytestocks: $CGEN News Article - Compugen Reports Fourth Quarter and Full Year 2022 Results | whytestocks | investorshangout | 02/27/2023 8:20:49 PM |
whytestocks: $CGEN News Article - 4 Cheap Penny Stocks To Buy For Under $1 Right Now | whytestocks | investorshangout | 11/17/2022 7:45:51 PM |
whytestocks: $CGEN News Article - Compugen to Receive Milestone Payment Triggered by AstraZeneca's P | whytestocks | investorshangout | 11/16/2022 3:15:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Compugen Ltd. Company Name:
CGEN Stock Symbol:
NASDAQ Market:
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 PR Newswire HOLON, Israel , April 10, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pione...
Compugen to Participate in Two Upcoming Investor Conferences PR Newswire HOLON, Israel , April 3, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, tod...
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy PR Newswire HOLON, Israel , March 11, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in ...